Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
141 stocks worldwide match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| JATT | JATT II Acquisition Corp. | Oncology | $93.68M | $12.01 | −49.45% | +7.81% |
| ACRV | Acrivon Therapeutics, Inc. | Oncology | $93.42M | $2.08 | −41.57% | +35.06% |
| 4579.T | RaQualia Pharma Inc. | Oncology | $93.23M | 568.00 JPY | −61.23% | +25.39% |
| OSE.PA | OSE Immunotherapeutics SA |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| $88.75M |
| 3.21 EUR |
| −58.29% |
| −0.19% |
| MAIA | MAIA Biotechnology, Inc. | Oncology | $84.56M | $1.39 | −56.43% | +12.10% |
| VRCA | Verrica Pharmaceuticals Inc. | Oncology | $84.35M | $4.91 | −50.01% | −9.07% |
| 0QW5.L | Heidelberg Pharma AG | Oncology | $84.14M | 2.46 EUR | −45.58% | 0.00% |
| CTOR | Citius Oncology, Inc. | Oncology | $83.24M | $0.79 | −65.02% | +45.49% |
| 0J4V.L | Heron Therapeutics, Inc. | Oncology | $82.85M | $0.31 | −80.47% | −3.55% |
| POLB.L | Poolbeg Pharma PLC | Oncology | $82.41M | 8.60 GBP | −6.52% | +36.51% |
| 4888.T | Stella Pharma Corporation | Oncology | $80.24M | 353.00 JPY | −64.52% | +18.06% |
| 0QXX.L | Molecular Partners AG | Oncology | $79.34M | 3.51 CHF | −10.91% | +2.33% |
| ELTX | Elicio Therapeutics, Inc. | Oncology | $78.32M | $2.98 | −81.38% | +1.02% |
| APLM | Apollomics, Inc. | Oncology | $76.75M | $26.20 | −37.80% | +43.80% |
| OSTX | OS Therapies Incorporated | Oncology | $76.68M | $1.65 | −35.80% | +10.00% |
| CRDF | Cardiff Oncology, Inc. | Oncology | $76.56M | $0.98 | −70.27% | +20.01% |
| PLRX | Pliant Therapeutics, Inc. | Oncology | $73.69M | $1.16 | −40.51% | +8.41% |
| XBIT | XBiotech Inc. | Oncology | $70.43M | $2.31 | −36.01% | +1.76% |
| SAR.L | Sareum Holdings plc | Oncology | $70.10M | 37.00 GBP | −2.63% | +76.19% |
| PMVP | PMV Pharmaceuticals, Inc. | Oncology | $70.03M | $1.31 | −30.32% | +19.09% |
| RNXT | RenovoRx, Inc. | Oncology | $67.24M | $1.49 | −4.49% | +64.28% |
| BOLD | Boundless Bio, Inc. | Oncology | $66.31M | $2.92 | −7.87% | +18.02% |
| MAAT.PA | MaaT Pharma SA | Oncology | $65.60M | 3.04 EUR | −64.73% | +8.96% |
| XLO | Xilio Therapeutics, Inc. | Oncology | $59.55M | $9.05 | −28.96% | −1.09% |
| HRTX | Heron Therapeutics, Inc. | Oncology | $59.27M | $0.31 | −80.24% | −36.29% |
| 4564.T | OncoTherapy Science, Inc. | Oncology | $56.36M | 21.00 JPY | −38.24% | +5.00% |
| IMMP | Immutep Limited | Oncology | $56.00M | $0.38 | −89.24% | −2.56% |
| 0OCQ.L | Transgene SA | Oncology | $55.45M | 0.81 EUR | −46.13% | −0.25% |
| ATX.AX | Amplia Therapeutics Limited | Oncology | $54.23M | 0.15 AUD | −47.27% | +11.54% |
| IMM.AX | Immutep Limited | Oncology | $54.01M | 0.05 AUD | −89.15% | +8.51% |
| 4572.T | Carna Biosciences, Inc. | Oncology | $53.63M | 402.00 JPY | −21.48% | +37.67% |
| TIL | Instil Bio, Inc. | Oncology | $53.10M | $7.83 | −76.86% | +7.41% |
| 0RAD.L | OSE Immunotherapeutics SA | Oncology | $51.87M | 3.19 EUR | −58.27% | −1.30% |
| 4597.T | Solasia Pharma K.K. | Oncology | $51.40M | 30.00 JPY | −28.57% | +3.45% |
| CANTA.ST | Cantargia AB (publ) | Oncology | $51.16M | 1.91 SEK | −71.02% | +3.24% |
| PTX.AX | Prescient Therapeutics Limited | Oncology | $50.63M | 0.07 AUD | −46.40% | −17.28% |
| IBO | Impact BioMedical Inc. | Oncology | $49.62M | $0.44 | −46.98% | +2.35% |
| COIL.L | Coiled Therapeutics plc | Oncology | $49.30M | 9.50 GBP | −68.33% | −9.52% |
| BKHA | Black Hawk Acquisition Corporation | Oncology | $49.21M | $11.85 | −9.56% | −2.09% |
| HOWL | Werewolf Therapeutics, Inc. | Oncology | $48.05M | $0.99 | −58.45% | +120.22% |
| SVE.WA | Synthaverse S.A. | Oncology | $47.18M | 3.06 PLN | −37.55% | +9.29% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | Oncology | $46.19M | 53.00 JPY | −44.79% | +15.22% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | Oncology | $44.46M | $1.96 | −82.17% | −72.36% |
| 4583.T | Chiome Bioscience Inc. | Oncology | $42.82M | 86.00 JPY | −39.86% | +26.47% |
| MOC.WA | Molecure S.A. | Oncology | $41.03M | 6.03 PLN | −33.30% | −2.58% |
| CNTX | Context Therapeutics Inc. | Oncology | $40.00M | $0.42 | −88.30% | −28.31% |
| 206A.T | PRISM BioLab Co.,LTD | Oncology | $39.48M | 170.00 JPY | −39.07% | +18.06% |
| SNT.AX | Syntara Limited | Oncology | $38.09M | 0.03 AUD | −32.50% | +22.73% |
| BCT.TO | BriaCell Therapeutics Corp. | Oncology | $35.23M | 5.62 CAD | −72.45% | +15.64% |
| BCTX | BriaCell Therapeutics Corp. | Oncology | $35.06M | $4.03 | −72.55% | +16.14% |
| 190A.T | CHORDIA THERAPEUTICS INC | Oncology | $33.98M | 72.00 JPY | −61.90% | −1.37% |
| KYNB | Kyntra Bio, Inc. | Oncology | $32.82M | $8.11 | −35.67% | +16.20% |
| ATNM | Actinium Pharmaceuticals, Inc. | Oncology | $31.69M | $1.01 | −44.08% | +16.49% |
| MDNA.TO | Medicenna Therapeutics Corp. | Oncology | $31.26M | 0.47 CAD | −76.14% | +32.39% |
| 4582.T | SymBio Pharmaceuticals Limited | Oncology | $31.19M | 63.00 JPY | −72.49% | −4.55% |
| BYSI | BeyondSpring Inc. | Oncology | $28.37M | $0.69 | −71.72% | −41.77% |
| CVM | CEL-SCI Corporation | Oncology | $28.32M | $1.61 | −88.06% | +34.17% |
| NNG.WA | NanoGroup S.A. | Oncology | $28.00M | 2.38 PLN | −25.63% | −4.80% |
| LTRN | Lantern Pharma Inc. | Oncology | $27.87M | $2.18 | −53.65% | −16.15% |
| NXTC | NextCure, Inc. | Oncology | $27.05M | $5.83 | −62.96% | +7.56% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.